Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
Tiuri E. Kroese(University of Zurich), Ewen A. Griffiths(Queen Elizabeth Hospital Birmingham), Maria Bencivenga(University of Verona), Theodore Liakakos(National and Kapodistrian University of Athens), Sebastian F. Schoppmann(Comprehensive Cancer Center Vienna), Manuel Pera, Guillaume Piessen(Centre Hospitalier Universitaire de Lille), Pieter Deseyne(Ghent University Hospital), M. Hawkins(University College Hospital), María Alsina(Vall d'Hebron Hospital Universitari), Matthias Gückenberger(University Hospital of Zurich), Johanna W. van Sandick(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Piotr Kołodziejczyk(Jagiellonian University), Radka Obermannová(Masaryk University), Antoine Adenis(Inserm), Stefan Mönig(Hôpital Beau-Séjour), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Sheraz R. Markar(Imperial College London), Paul M. Jeene(Radiotherapiegroep), John V. Reynolds(Trinity College), Grard A. P. Nieuwenhuijzen(Radboud University Nijmegen), Markus Moehler(Johannes Gutenberg University Mainz), A.G. Morganti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Cihan Gani(German Cancer Research Center), Laurens V. Beerepoot(Elisabeth-TweeSteden Ziekenhuis), Wojciech Polkowski(Medical University of Lublin), Richard van Hillegersberg(University Medical Center Utrecht), Christiane J. Bruns, Florian Lordick(Leipzig University), Franco Roviello(University of Siena), Philippe Nafteux(KU Leuven), Marije Slingerland(Leiden University Medical Center), Riccardo Rosati(Universität Hamburg), Giovanni De Manzoni(University of Verona), Ines Gockel(University Hospital of Basel), Per Pfeiffer(University of Southern Denmark), Dorothea Wagner(University of Lausanne), Carlo Castoro(Humanitas University), Marianne Nordsmark(Aarhus University Hospital), Magnus Nilsson(Karolinska University Hospital), C.T. Muijs(University Medical Center Groningen), Maaike Berbée(Maastro Clinic), Edward Cheong(Norfolk and Norwich University Hospitals NHS Foundation Trust), George B. Hanna(University of London), Elizabeth Smyth(Cambridge University Hospitals NHS Foundation Trust), Lucjan Wyrwicz(The Maria Sklodowska-Curie National Research Institute of Oncology), Anneli Elme(North Estonia Medical Centre), Asif Chaudry(University of London), Domenico D’Ugo(Agostino Gemelli University Polyclinic)
Cited by 43
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Gastric cancer
|The Lancet|2020|4.8k